Skip to main content
. 2022 Feb 3;11:23. doi: 10.1186/s13756-022-01072-4

Table 2.

Antimicrobial susceptibility profiles of the most common gram-positive bacteria

Antimicrobials S. aureus S. pneumoniae S. pyogenes Enterococcus spp S. viridians
R
n (%)
S
n (%)
R
n (%)
S
n (%)
R
n (%)
S
n (%)
R
n (%)
S
n (%)
R
n (%)
S
n (%)
AMP 46 (86.8) 7 (13.2) 1 (50) 1 (50) 1 (100) 0 (0) 3 (50) 3 (50) 1 (100) 0 (0)
A 1 (100) 0 (0) c c a a c c a a
FOX 17 (32.7) 33 (63.5) c c c c c c c c
SXT 39 (66.1) 19 (32.2) 1 (100) 0 (0) c c c c c c
CIP 21 (52.5) 18 (45) c c c c 2 (100) 0 (0) c c
CN 51 (52.6) 46 (46.9) c c c c c c 1 (100) 0 (0)
P a a a a a a a a a a
VAN 13 (13.7) 82 (86.3) 0 (0) 1 (100) 0 (0) 1 (100) 1 (33.3) 2 (66.7) 0 (0) 1 (100)
AMC c c 1 (50) 1 (50) c c c c c c
C 28 (42.4) 38 (57.6) 1 (100) 0 (0) a a a a a a
DA 9 (19.1) 38 (80.9) a a a a c c a a
E c c a a 1 (100) 0 (0) 1 (50) 1 (50) 1 (100) 0 (0)
N 1 (16.7) 5 (83.3) c c c c 1 (100) 0 (0) c c
CTX c c a a a a c c a a
IMP c c a a a a c c a a
CRO c c a a a a c c a a
TE 12 (80) 2 (13.3) a a a a 0 (0) 3 (100) a a
CXM c c a a a a c c c c
RIF 3 (16.7) 15 (83.3) 0 (0) 1 (100) c c 1 (50) 1 (50) c c
AZT c c c c c c c c c c

R—Resistant, S—Sensitive, %—bacteria screened against a particular antimicrobial, a and c—antimicrobial not screened against the bacteria (due to c—CLSI guidelines or a—total absence or unavailability in the lab), AMP—Ampicillin, A—Azithromycin, FOX—Cefoxitin, CN—Gentamicin, IPM—Imipenem, CIP—Ciprofloxacin, CTX—Cefotaxime, AZT—Aztreonam, AMC—Amoxicillin-clavulanic acid, N—Nitrofurantoin, SXT—Cotrimoxazole, CXM—Cefuroxime, CRO—Ceftriaxone, C—Chloramphenicol, P—Penicillin, VAN—Vancomycin, DA—Clindamycin, E—Erythromycin, TE—Tetracycline, RIF—Rifampicin